Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial

Overview of attention for article published in Journal of Clinical Oncology, March 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 25 news stories from 12 outlets.

The latest developments in systemic therapy for very high-risk localized and oligometastatic prostate cancer were reviewed…

Oncology/Hematology > Prostate Cancer Use of chemo reduced radiation-induced cancers, and may prolong OS in low-PSA subgroup…

One-fifth of men with high-risk localized prostate cancer (PCa) receive treatment that is not standard of care, according to a…

Adding docetaxel to androgen suppression and radiation therapy for selected men with high-risk localized prostate cancer (PCa…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 21 additional news stories.